Starten Sie Ihre Suche...


Durch die Nutzung unserer Webseite erklären Sie sich damit einverstanden, dass wir Cookies verwenden. Weitere Informationen

Institut für translationale Immunologie (TIM)

Vorklinik / Johannes Gutenberg-Universität Mainz

Publikationen
Ergebnisse pro Seite:  10

Ziegler, Kira; Neumann, Jan; Liu, Fobang et al.

Nitration of Wheat Amylase Trypsin Inhibitors Increases Their Innate and Adaptive Immunostimulatory Potential in vitro

FRONTIERS IN IMMUNOLOGY. Bd. 9. 2019


Khan, ?; Aslam, ?; Senkowski, Marcel S. et al.

NUTRITIONAL WHEAT AMYLASE TRYPSIN INHIBITORS (ATI) PROMOTE PROGRESSION OF MURINE PRIMARY HEPATOCELLULAR CARCINOMA

HEPATOLOGY. Bd. 70. 2019 S. 1231A-1231A


Darwish, Ghassan; Helmerhorst, Eva J.; Schuppan, Detlef et al.

Pharmaceutically modified subtilisins withstand acidic conditions and effectively degrade gluten in vivo

SCIENTIFIC REPORTS. Bd. 9. 2019


Gore, Emilia; Bigaeva, Emilia; Oldenburger, Anouk et al.

PI3K inhibition reduces murine and human liver fibrogenesis in precisioncut liver slices

BIOCHEMICAL PHARMACOLOGY. Bd. 169. 2019


Aslam, Misbah; Ashfaq-Khan, Muhammad; Qureshi, Asif et al.

Rapamycin promotes tumoricidal immunity in murine HCC by inducing M1-type macrophages and dentritic cells polarization and enhancement of cytotoxic T-cells

JOURNAL OF HEPATOLOGY. Bd. 70. H. 1. 2019 S. E595-E595


Kim, Yong Ook; Park, Kyoung-Sook; Schuessler, Christoph et al.

RAPIDLY PROGRESSIVE, POLYCLONAL ORTHOTOPIC HEPATOCELLULAR CARCINOMA (HCC) IN MDR2 (abcb4) KNOCKOUT MICE TREATED WITH DIETHYLNITROSAMINE AND PHENOBARBITAL

HEPATOLOGY. Bd. 70. 2019 S. 1208A-1209A


Rinella, Mary E.; Tacke, Frank; Sanyal, Arjun J. et al.

Report on the AASLD/EASL Joint Workshop on Clinical Trial Endpoints in NAFLD

HEPATOLOGY. 2019


Rinella, Mary E.; Tacke, Frank; Sanyal, Arun J. et al.

Report on the AASLD/EASL joint workshop on clinical trial endpoints in NAFLD

JOURNAL OF HEPATOLOGY. Bd. 71. H. 4. 2019 S. 823-833



Nielsen, Mette Juul; Villesen, Ida Falk; Gudmann, Natasja Staehr et al.

Serum markers of type III and IV procollagen processing predict recurrence of fibrosis in liver transplanted patients

SCIENTIFIC REPORTS. Bd. 9. 2019